Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B

被引：0
|
作者：
Juan Li
Chunhua Hu
Yi Chen
Rou Zhang
Shan Fu
Mimi Zhou
Zhijie Gao
Mengjun Fu
Taotao Yan
Yuan Yang
Jianzhou Li
Jinfeng Liu
Tianyan Chen
Yingren Zhao
Yingli He
机构：
[1] First Affiliated Teaching Hospital,Department of Infectious Diseases
[2] School of Medicine,undefined
[3] Xi’an Jiaotong University,undefined
[4] Institution of Hepatology,undefined
[5] First Affiliated Teaching Hospital,undefined
[6] School of Medicine,undefined
[7] Xi’an Jiaotong University,undefined
[8] Shaanxi Clinical Research Center of Infectious Diseases,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
Tenofovir alafenamide; Tenofovir disoproxil fumarate; Entecavir; Hepatitis B virus; Acute-on-chronic liver failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, W. Ray
    Loomba, Rohit
    Berg, Thomas
    Schall, Raul E. Aguilar
    Yee, Leland J.
    Dinh, Phillip V.
    Flaherty, John F.
    Martins, Eduardo B.
    Therneau, Terry M.
    Jacobson, Ira
    Fung, Scott
    Gurel, Selim
    Buti, Maria
    Marcellin, Patrick
    CANCER, 2015, 121 (20) : 3631 - 3638
  • [42] Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B
    Chang, Te-Sheng
    Yang, Yao-Hsu
    Chen, Wei-Ming
    Shen, Chien-Heng
    Tung, Shui-Yi
    Yen, Chih-Wei
    Hsieh, Yung-Yu
    Lee, Chuan-Pin
    Tsai, Meng-Ling
    Hung, Chao-Hung
    Lu, Sheng-Nan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] THE SHORT-TERM EFFICACY OF ANTIVIRAL TREATMENT IN PATIENTS WITH ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILURE
    Qihuan, X.
    Lubiao, C.
    Xin, S.
    Zhen, X.
    Ni, C.
    Qifeng, X.
    Gang, L.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S392 - S392
  • [44] EFFECTIVENESS AND SAFETY OF SWITCHING TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR TO TENOFOVIR ALAFENAMIDE FUMARATE ( TAF) IN VIROLOGICALLY SUPPRESSED CHRONIC HEPATITIS B VIRUSINFECTED PATIENTS WITH ONEMINUTE OSTEOPOROSIS RISK TEST
    Li, Hui
    Li, Chunmei
    Wei, Jia
    Liu, Yunhua
    Gong, Ming
    Zhang, Ruyi
    Geng, Jiawei
    Wang, Hongyan
    Yu, Zhijian
    Wang, Zi
    Liu, Xiang
    HEPATOLOGY, 2023, 78 : S513 - S513
  • [45] Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
    Heathcote, E. Jenny
    Marcellin, Patrick
    Buti, Maria
    Gane, Edward
    De Man, Robert A.
    Krastev, Zahary
    Germanidis, George
    Lee, Samuel S.
    Flisiak, Robert
    Kaita, Kelly
    Manns, Michael
    Kotzev, Iskren
    Tchernev, Konstantin
    Buggisch, Peter
    Weilert, Frank
    Kurdas, Oya Ovunc
    Shiffman, Mitchell L.
    Trinh, Huy
    Gurel, Selim
    Snow-Lampart, Andrea
    Borroto-Esoda, Katyna
    Mondou, Elsa
    Anderson, Jane
    Sorbel, Jeff
    Rousseau, Franck
    GASTROENTEROLOGY, 2011, 140 (01) : 132 - 143
  • [46] Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
    Bahri Abayli
    Cansu Abayl?
    Genco Gencdal
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2021, 12 (02) : 32 - 39
  • [47] Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Virus Infection in the African American Community
    Mor, Yechiel
    Wang, Jing
    Rizwan, Aliza
    Badia, Victoria
    Naylor, Paul
    Ehrinpreis, Murray
    Mutchnick, Milton G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S537 - S538
  • [48] Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
    He, Jingjing
    Guo, Yifei
    Zhang, Yao
    Han, Jiajia
    Chen, Jingwen
    Jia, Yidi
    Ma, Zhenxuan
    Wu, Jingwen
    Zhang, Shenyan
    Li, Fahong
    Mao, Richeng
    Zhang, Jiming
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 3929 - 3941
  • [49] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B
    Zhang, Xueyun
    Hu, Qiankun
    Liu, Xiaoqin
    Huang, Yuxian
    HEPATOLOGY, 2021, 74 : 490A - 491A
  • [50] COST-EFFECTIVENESS OF SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE VS. ENTECAVIR FOR CHRONIC HEPATITIS B PATIENTS IN GREECE
    Sinakos, E.
    Kachru, N.
    Tsoulas, C.
    Jeyakumar, S.
    Smith, N.
    Yehoshua, A.
    Cholongitas, E.
    VALUE IN HEALTH, 2023, 26 (06) : S82 - S83
12345